In this edition:
INSPIRE: Risankizumab in ulcerative colitis
SPICY: extended mesenterectomy in primary ileocolic resection for Crohn’s disease
Obefazimod in ulcerative colitis
LUCENT: Extended induction response with mirikizumab in ulcerative colitis
Risankizumab & intestinal stenosis in Crohn’s disease
Early childhood physical activity & subsequent IBD
Epi-IBD: Crohn’s disease course
ACCURE: appendectomy & ulcerative colitis
GETTECU: Withdrawal of anti-TNF therapy for IBD
QUASAR: guselkumab induction therapy for ulcerative colitis
Please login below to download this issue (PDF)